Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19
Covid19, Vaccine Refusal
About this trial
This is an interventional health services research trial for Covid19
Eligibility Criteria
Inclusion Criteria:
- Patients in the Mass General Brigham system
- Aged 18 and older
- Are eligible for the COVID booster vaccine but have not received a dose at time of upcoming primary care clinic visit
Exclusion Criteria:
- Documented allergy to a COVID vaccine or its components
- Home address outside of Massachusetts
- Did not receive full set of primary COVID-19 vaccination series
Sites / Locations
- Mass General Brigham
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
"Why" messaging
"How" messaging
Usual Care
In this arm, patients will be sent an electronic patient portal message a few days in advance of their office visit. Messages will focus on reasons to get the COVID booster vaccine, including protecting self and loved ones or the idea of herd immunity.
In this arm, patients will be sent an electronic patient portal message a few days in advance of their office visit. "How" messages will focus on the details of obtaining a vaccination at MGB, what to expect, and how to prepare for the visit.
In this arm, patients will not receive any additional message about their upcoming visit, beyond what they already receive by the health system.